The city of Pasadena, California, currently has 1 active clinical trials seeking participants for Amyotrophic Lateral Sclerosis research studies.
AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy
Recruiting
The purpose of this research study is to assess safety and tolerability of a single intravenous (given through a vein) dose of the investigational retinal tracer AMDX-2011P in patients with neurodegenerative diseases (Parkinson's disease and ALS).
Gender:
All
Ages:
18 years and above
Trial Updated:
01/31/2023
Locations: Brittany NIcholl, Pasadena, California
Conditions: Parkinson Disease, Amyotrophic Lateral Sclerosis